Tempest Therapeutics, Inc. — Director's Dealing 2018

Dec 12, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Millendo Therapeutics, Inc. (MLND)
CIK: 0001544227
Period of Report: 2018-12-07

Reporting Person: FHM VI, L.L.C. (10% Owner)
Reporting Person: FHM VI, L.P. (10% Owner)
Reporting Person: Frazier Healthcare VI, L.P. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1396615	Indirect

Footnotes

F1: The securities are held by Frazier Healthcare VI, L.P. ("Frazier VI"). FHM VI, L.P. ("FHM LP") is the general partner of Frazier VI and FHM VI, L.L.C. ("FHM LLC") is the general partner of FHM LP. Each of FHM LLC and FHM LP disclaims beneficial ownership of all shares held by Frazier VI except to the extent, if any, of such entity's, as applicable, pecuniary interest therein.